A A A A A AA
escribers 1st Edition Luu Kayingo complete g
A A A A AA A
uide with rationale
A A
, Table of Contents
A A
ChapterA 1:A AnA IntroductionA toA Evidence-BasedA ClinicalA PracticeA Guidelines ........................................... 3
ChapterA 2:A PharmacokineticsA /Chapter3:A Pharmacodynamics ................................................................... 13
Chapter4:A PharmacogeneticsA andA Pharmacogenomics ............................................................................... 25
ChapterA 5:A PharmacologyA AcrossA theA LifeA Span....................................................................................... 30
ChapterA 6:A Drug-TherapyAPrescribingAinA SpecialA Populations .................................................................. 36
ChapterA 7:A DrugADevelopmentA andA Approval ........................................................................................... 45
ChapterA 8-ChapterA 10:A FoundationsA ofA PrescriptionA WritingA ChapterA 9:A ResponsibleControlled-
ASubstanceA PrescribingAChapterA 10:AAntibioticA Stewardship ..................................................................... 51
ChapterA 11:A AppliedACalculationsA forA Prescribing .................................................................................... 58
ChapterA12-:APromotingAAdherenceAWithAPharmacotherapyAII:ASystem-SpecificAandAPatient-
FocusedAPrescribingA ChapterA 13:A PharmacotherapyA forAEar,A Nose,AMouth,A andThroatA ConditionsA/Chap
teA rA 14:A PharmacotherapyAforA EyeAConditions .......................................................................................... 67
ChapterA 15:A PharmacotherapyA forA SkinA Conditions .................................................................................. 74
ChapterA 16:APharmacotherapyA forA NeurologicA Conditions........................................................................ 81
ChapterA 17:A PharmacotherapyA forA CardiovascularA Conditions ................................................................. 94
ChapterA 18:A PharmacotherapyA forA RespiratoryA Conditions ..................................................................... 106
ChapterA19:APharmacotherapyAforAGastrointestinalAConditionsAandAConditionsARequiringNutritionalASupp
Aort ............................................................................................................................................................. 117
ChapterA 20:APharmacotherapyA forA GenitourinaryA Conditions ................................................................. 128
ChapterA 21:A PharmacotherapyA forA Renal,A Acid–Base,A Fluid,A andA ElectrolyteADisorders ...................... 133
ChapterA 22:A PharmacotherapyA forA MusculoskeletalA andA RheumatologicA Conditions ............................ 146
ChapterA 23:A TherapeuticA ApplicationsA ofA ImmunologyA andA Vaccines................................................... 158
ChapterA 24:A PharmacotherapyA forA EndocrineA Disorders ......................................................................... 163
ChapterA 25:APharmacotherapyA forA HematologicA Disorders ..................................................................... 174
ChapterA 26:A Hematology/OncologyA andASupportiveA CareAforA theA Nononcologist ................................. 190
ChapterA 27:A PharmacotherapyA RelatedA toA Women’sA HealthA Conditions................................................ 196
ChapterA 28:A PharmacotherapyA RelatedA toAMen’sA HealthA Conditions ..................................................... 211
ChapterA 29:A PharmacotherapyA RelatedA toATransgenderA Care ................................................................. 217
ChapterA 30:A AntimicrobialA Pharmacotherapy ........................................................................................... 224
ChapterA 31:A AntiretroviralA Pharmacotherapy ........................................................................................... 235
ChapterA32:APsychopharmacologyAandAIntegrativeAHealth:ACombinedATreatmentAofPsychiatricAandANeuro
AcognitiveAConditions ................................................................................................................................ 247
ChapterA 33:A PharmacotherapyA forA PainAManagement ............................................................................. 257
ChapterA 34:A SubstanceA UseADisorderA III:A HealthA PromotionA andAMaintenance..................................... 267
ChapterA 35:AOver-the-CounterA Medications ............................................................................................. 283
ChapterA 36:A PharmacotherapyA forA Obesity .............................................................................................. 291
,ChapterA1:AAnAIntroductionAtoAEvidence-BasedAClinicalAPracticeAGuidelines
MULTIPLEA CHOICE
• WhatAisAtheA primaryA purposeA ofA theA nursingA assessment?
A. IdentifyingA underlyingA pathologicA conditions
B. AssistingA theA physicianA inAidentifyingA medicalA conditions
C. DeterminingA theA patientsAmentalAstatus
D. ExploringA patientA responsesA toA healthA problems
ANS:AD
AAnursingAassessmentAisAdoneAtoAidentifyAtheApatientsAresponseAtoAhealthAp
rAoblems.ADuringAtheAnursingAassessmentAphase,AaAcomprehensiveAinforma
tiAonAbaseAisAdevelopedAthroughAaAphysicalAexamination,AnursingAhistory,A
meAdicationAhistory,AandAprofessionalAobservation.AIdentifyingAunderlying
ApathAologicAconditionsAandAassistingAtheAphysicianAinAidentifyingAmedical
AconditAionsAisAnotApartAofAtheAnursingAprocess.ADeterminingAtheApatientsA
mentalAstAatusA isAoneApartA ofAtheA nursingA assessment,A butA itA isA notAtheAp
rimaryApurpAose.
DIF:ACognitiveALevel:AComprehension
AREF:AdmA36AOBJ:A1A|A3ATOP:ANursin
gAProcessAStep:AAssessment
MSC:ANCLEXA ClientA NeedsA Category:A HealthA PromotionAandA Maintenance
• WhatAisAtheA basisA ofAtheA NANDAAIA taxonomy?
A. FunctionalA healthApatterns
B. HumanA responseA patterns
C. BasicA humanA needs
D. PathophysiologicA needs
ANS:AB
TheA NANDAA IA taxonomyA identifiesA humanA responseA patterns.AFuncti
oAnalAcomponentsAofAhealthApatternsAareAlimitedAtoAactivity,AfluidAvolume
,AnAutrition,AselfAcare,AandAsensoryAperception.ABasicAhumanAneedsAcompr
iseAlAessAthanAmerelyAhealthApatterns.A PathophysiologicAneedsA areAnotApa
rtAofAtAheAscopeAofANANDAAI.
, DIF:ACognitiveALevel:AKnowledgeARE
AF:App.A37-38AOBJ:A5ATOP:
NursingA ProcessA Step:ADiagnosis
MSC:ANCLEXA ClientA NeedsA Category:A PhysiologicalA Integrity
• WhichAtaskA isAincludedA inAtheA assessmentA stepA ofAtheA nursingA process?
A. EstablishingA patientA goals/outcomes
B. ImplementingA theA nursingA careA planA (NCP)
C. MeasuringA goal/outcomeA achievement
D. CollectingA andA communicatingA data
ANS:RD
DataAareAcollectedAandAcommunicatedAinAtheAassessmentAphaseAofAtheAnur
siAngAprocess.AEstablishingAgoalsAisAtheAfunctionAofAplanning.
ImplementingAtheANCPAisAtheAfunctionAofAimplementation.AMeasuringAout
cAomeAachievementAisAtheAfunctionAofAevaluation.
DIF:ACognitiveALevel:AComprehension
AREF:AdmA36AOBJ:A2A|A3ATOP:ANursin
gAProcessAStep:AAssessment
MSC:ANCLEXA ClientA NeedsA Category:A HealthA PromotionAandA Maintenance
• WhichAstatementA regardingA nursingA diagnosesA isA accurate?
a. NursingA diagnosesA remainAtheA sameA forAasA longAasAtheA diseaseA isA present.
b. NursingA diagnosesA areA writtenA toA identifyAdiseaseAstates.
c. NursingA diagnosesA describeA patientA problemsA thatA nursesA treat.
d. NursingA diagnosesA identifyA causesA relatedA toA illness.
ANS:AC
DiagnosticAstatementsAidentifyAproblemsAaAnurseAisAindependentlyAableAt
oAtreatAwithinAtheAscopeAofAprofessionalApractice.ANursingAdiagnosesAvary
AwiAthAtheAchangingAconditionAofAtheApatient.ATheAresponseApatternsAareAu
niqueAtoAtheA patientAandAareAnotAdiseaseAspecific.A NursingAdiagnosesA des
cribeAthA eApatientsAhumanAresponseApattern.
DIF:A CognitiveA Level:A Comprehension